AGAM Biological Products

Company Overview

Snapshot

Founded in June 2008 by Sam Angel, Ph.D., AGAM Biological Products operates with 1–10 employees. The company holds a patent and has released its MatriSea product, a three-dimensional collagen-based scaffold, to researchers.

Business overview

AGAM Biological Products specializes in developing collagen-based products derived from jellyfish for medical, cosmetic, and nutritional applications. The company's core technology focuses on extracting and processing collagen to create solutions such as wound dressings for chronic wounds and collagen skin substitutes for third-degree burns. AGAM serves the healthcare and life sciences sectors, specifically within pharmaceuticals and tissue regeneration, and offers its MatriSea product to researchers for cell culture studies.

Strategic signal

In January 2015, AGAM Biological Products secured a patent registration in Europe. This milestone indicates the company's commitment to protecting its intellectual property and expanding its market reach for its collagen-based technologies within the European pharmaceutical and medical biotechnology landscape.

Company Intelligence Q&A

What is AGAM Biological Products' primary focus?

AGAM Biological Products focuses on developing collagen-based products for various medical, cosmetic, and nutritional applications, utilizing collagen extracted from jellyfish.

Who founded AGAM Biological Products?

AGAM Biological Products was founded by Sam Angel, Ph.D.

What product has AGAM Biological Products released?

AGAM Biological Products has released MatriSea, a three-dimensional collagen-based scaffold, which is sold to researchers for cell culture research.

What markets does AGAM Biological Products serve?

AGAM Biological Products serves the healthcare and life sciences sectors, with a focus on pharmaceuticals and tissue regeneration.

When did AGAM Biological Products secure a patent in Europe?

In January 2015, AGAM Biological Products secured a patent registration in Europe.